Author

Ron Tintner

Observed names: R TINTNER, R Tintner, R. Tintner, Ronald Tintner, Tintner, Ron

Observed institutions: Houston Methodist, National Institutes of Health, Baylor St. Luke's Medical Center, The University of Texas at Dallas, Baylor College of Medicine, University of Florida Health, University of Florida, Massachusetts General Hospital, Palo Alto Veterans Institute for Research, University of Texas Health Science Center at Dallas, National Institute of Neurological Disorders and Stroke, The University of Texas Southwestern Medical Center, Stanford University

OpenAlex ID: A5110127229

Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing

1992 · Mikio Shoji, Todd E. Golde, et al. · Science · 1,447

Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's disease

2005 · William G. Ondo, Ron Tintner, et al. · Movement Disorders · 297

Reliability of a new scale for essential tremor

2012 · Rodger Elble, Cynthia Comella, et al. · Movement Disorders · 244

Intrafamilial phenotypic variability of the DYT1 dystonia: From asymptomatic TOR1A gene carrier status to dystonic storm

2002 · Puneet Opal, Ron Tintner, et al. · Movement Disorders · 136

Dystonia and parkinsonism

2001 · Joseph Jankovic, Ron Tintner · Parkinsonism & Related Disorders · 135

Striatal deformities of the hand and foot in Parkinson's disease

2005 · Ramsey Ashour, Ron Tintner, et al. · The Lancet Neurology · 120

Benefits and Risks of Pharmacological Treatments for Essential Tremor

2003 · Kelly E Lyons, Rajesh Pahwa, et al. · Drug Safety · 103

Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice

1978 · Richard L. Delanoy, Adrian J. Dunn, et al. · Hormones and Behavior · 96

Autonomic function after botulinum toxin type A or B: A double-blind, randomized trial

2005 · R. Tintner, R. Gross, et al. · Neurology · 93

Tetrabenazine Treatment for Huntington's Disease-Associated Chorea

2002 · William G. Ondo, Ron Tintner, et al. · Clinical Neuropharmacology · 89

Brain blood flow in the dementias: SPECT with histopathologic correlation.

1993 · F J Bonte, R Tintner, et al. · Radiology · 65

Pleuropulmonary Fibrosis After Long-term Treatment With the Dopamine Agonist Pergolide for Parkinson Disease

2005 · Ron Tintner, Prasad Manian, et al. · Archives of Neurology · 64

Single photon tomography in Alzheimer's disease and the dementias

1990 · F.J. Bonte, J. Hom, et al. · Seminars in Nuclear Medicine · 55

Treatment options for Parkinsonʼs disease

2002 · Ron Tintner, Joseph Jankovic · Current Opinion in Neurology · 48

Neuropathologic verification of Creutzfeldt‐Jakob disease in the exhumed American recipient of human pituitary growth hormone

1986 · Ron Tintner, Paul Brown, et al. · Neurology · 46

Botulinum toxin for the treatment of cervical dystonia

2001 · Joseph Jankovic, Ron Tintner · Expert Opinion on Pharmacotherapy · 40

Acetylcholine receptor antibodies in the Lambert‐Eaton myasthenic syndrome

1998 · J. S. Katz, G. I. Wolfe, et al. · Neurology · 40

The Effect of Acetazolamide on Regional Cerebral Blood Flow in Patients with Alzheimer??s Disease or Stroke as Measured by Single-Photon Emission Computed Tomography

1989 · F J BONTE, M D DEVOUS, et al. · Investigative Radiology · 39

Dopamine agonists in Parkinson?s disease

2003 · Ron Tintner, Joseph Jankovic · Expert Opinion on Investigational Drugs · 31

Factitious Disorder in a Geriatric Patient

1992 · Jana Gober Zimmerman, Richard A. Hussian, et al. · Clinical Gerontologist · 30

Experiences with depression in a dementia clinic.

1991 · M F Weiner, M Bruhn, et al. · PubMed · 27

Focal dystonia: The role of botulinum toxin

2001 · Ron Tintner, Joseph Jankovic · Current Neurology and Neuroscience Reports · 25

Cognitive deficits in asymptomatic first-degree relatives of Alzheimer's disease patients

1994 · Jim Hom, Mary B. Turner, et al. · Journal of Clinical and Experimental Neuropsychology · 25

Corticotrophin Increases Cerebral Polyamine Content

1979 · Ron Tintner, Adrian J. Dunn, et al. · Journal of Neurochemistry · 16

ACE inhibitor lacks acute effect on cognition or brain blood flow in alzheimer's disease

1992 · Myron F. Weiner, Frederick J. Bonte, et al. · Drug Development Research · 14

Works count: 37

Citation count: 3,354

H-index: 23

I10-index: 26